Atlas Trials

Immunogenicity and Safety of Sanofi Pasteur's CYD Dengue Vaccine in Healthy Children and Adolescents in Latin America

Clinical trial NCT00993447 · COMPLETED

Trial details

NCT number
NCT00993447
Sponsor
Sanofi Pasteur, a Sanofi Company
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
DengueDengue Hemorrhagic FeverDengue VirusDengue Fever
Start date
2009-10-01
Primary completion
2011-09-01
Enrollment
600

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.